HC Wainwright & Co. Maintains Buy on Biomea Fusion, Lowers Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Joseph Pantginis maintains a Buy rating on Biomea Fusion (NASDAQ:BMEA) but lowers the price target from $50 to $15.

June 07, 2024 | 4:59 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
HC Wainwright & Co. analyst Joseph Pantginis maintains a Buy rating on Biomea Fusion but significantly lowers the price target from $50 to $15.
The significant reduction in the price target from $50 to $15 suggests a more cautious outlook on Biomea Fusion's future performance, which could negatively impact investor sentiment and the stock price in the short term, despite the maintained Buy rating.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100